RoB 2: a revised tool for assessing risk of bias in randomised trials
2019 · BMJ · 29K citations
https://doi.org/10.1136/bmj.l4898
H
Hung‐Yuan Cheng
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
100
Papers
40.5K
Citations
33
h-index
53
i10-index
Hung‐Yuan Cheng is an academic researcher from University Hospitals Bristol NHS Foundation Trust. The author has contributed to research in topics: Electrochemical Analysis and Applications & High Altitude and Hypoxia & COVID-19 Clinical Research Studies. The author has an h-index of 33, co-authored 85 publications.
ORCID: 0000-0002-6162-4146Papers by this author
worksMolecular Properties That Influence the Oral Bioavailability of Drug Candidates
2002 · Journal of Medicinal Chemistry · 7,875 citations
https://doi.org/10.1021/jm020017n
Scope, quality, and inclusivity of clinical guidelines produced early in the covid-19 pandemic: rapid review
2020 · BMJ · 165 citations
https://doi.org/10.1136/bmj.m1936
Intraoperative interventions for preventing surgical site infection: an overview of Cochrane Reviews
2018 · Cochrane Database of Systematic Reviews · 136 citations
https://doi.org/10.1002/14651858.cd012653.pub2
Tibetans living at sea level have a hyporesponsive hypoxia-inducible factor system and blunted physiological responses to hypoxia
2013 · Journal of Applied Physiology · 133 citations
https://doi.org/10.1152/japplphysiol.00535.2013
Availability, scope and quality of monkeypox clinical management guidelines globally: a systematic review
2022 · BMJ Global Health · 56 citations
https://doi.org/10.1136/bmjgh-2022-009838
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat